Glenn H. Dillon

Pharmacology and Neuroscience University of North Texas Health Science Center at Fort Worth 
Pharmacology, Neuroscience Biology
"Glenn Dillon"
Mean distance: 21373.2
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Kumar M, Dillon GH. (2016) Assessment of direct gating and allosteric modulatory effects of meprobamate in recombinant GABAA receptors. European Journal of Pharmacology
Kumar M, González LA, Dillon GH. (2015) Assessment of subunit-dependent direct gating and allosteric modulatory effects of carisoprodol at GABAA receptors. Neuropharmacology
Kumar M, Dillon GH. (2015) Carisoprodol: Update on abuse potential and mechanism of action Molecular and Cellular Pharmacology. 7: 1-10
Huang R, Griffin SA, Taylor M, et al. (2013) The effect of SV 293, a D2 dopamine receptor-selective antagonist, on D2 receptor-mediated GIRK channel activation and adenylyl cyclase inhibition. Pharmacology. 92: 84-9
Li W, Huang R, Shetty RA, et al. (2013) Transient focal cerebral ischemia induces long-term cognitive function deficit in an experimental ischemic stroke model. Neurobiology of Disease. 59: 18-25
Gatch MB, Kozlenkov A, Huang RQ, et al. (2013) The HIV antiretroviral drug efavirenz has LSD-like properties. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 38: 2373-84
Luedtke RR, Mishra Y, Wang Q, et al. (2012) Comparison of the binding and functional properties of two structurally different D2 dopamine receptor subtype selective compounds. Acs Chemical Neuroscience. 3: 1050-62
Huang R, Singh M, Dillon GH. (2010) Genistein directly inhibits native and recombinant NMDA receptors. Neuropharmacology. 58: 1246-51
Gonzalez LA, Gatch MB, Forster MJ, et al. (2009) Abuse Potential of Soma: the GABA(A) Receptor as a Target. Molecular and Cellular Pharmacology. 1: 180-186
Gonzalez LA, Gatch MB, Taylor CM, et al. (2009) Carisoprodol-mediated modulation of GABAA receptors: in vitro and in vivo studies. The Journal of Pharmacology and Experimental Therapeutics. 329: 827-37
See more...